<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

true
true

CLAIM ID

4c19ef19

Burevi Cyclone hits Tamil Nadu.

Cyclone Burevi crossed the South Tamil Nadu coast between Pamban and Kanyakumari on Dec.3 with a 70-80 kph wind speed.

Cyclone Burevi crossed the South Tamil Nadu coast between Pamban and Kanyakumari on Dec.3 with a 70-80 kph wind speed.On Dec. 2, 2020, Burevi, an active tropical cyclone formed over the Southwest Bay of Bengal, moved West-Northwestwards and centered over Southwest Bay of Bengal and about 70 km East-Northeast Trincomalee, Sri Lanka, 290 km East-Southeast of Pamban and 480 km East-Northeast of Kanyakumari. It emerged in the Gulf of Mannar near Rameswaram in Tamil Nadu on Dec. 3.

India Meteorological Department (IMD) had predicted heavy to very high rainfall in Tamil Nadu's districts on Dec. 5 and severe rains in isolated areas. The storm would be associated with a 50-60 kph wind speed and weakens with deep depression for several hours. It then moves slowly west and southwestwards across the Ramanathapuram district towards South Kerala. IMD had issued a red alert on Dec. 4 to Tamil Nadu, Puducherry, and Karaikal.

PM Narendra Modi had a telephonic conversation with the Tamil Nadu Chief Minister Palaniswami and assured help from the Centre for the challenges faced due to cyclone Burevi. The state administration has made all efforts to ensure the safety of the fishermen in the deep-sea. Control rooms have been established in Kanyakumari, Thoothukudi, and Chennai on a 24-hour basis.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day

misleading

397 children were diagnosed with heart inflammation after receiving Pfizer’s COVID-19 vaccine in U.S.